Find uplifting stories about heroes, innovations, and solutions
2841 results for "fda regulations"
The FDA just launched two groundbreaking clinical trials that send safety data to regulators instantly, cutting years from the drug approval process. For patients waiting on life-saving treatments, this could change everything.
The FDA just announced a revolutionary approach that could cut years off the time it takes new treatments to reach patients. For the first time, regulators will monitor clinical trials as they happen, watching results unfold in real time instead of waiting months for reports.
A new artificial intelligence platform designed to improve post-surgical recovery just earned a major stamp of approval from federal regulators. RecovryAI's breakthrough designation from the FDA could accelerate how quickly patients get access to smarter recovery care.
After surprising companies with a rejection in January, the FDA has agreed that existing trial data for a rare blood cancer therapy is sufficient for approval review. The agency's reversal gives new hope to patients with limited treatment options.
The FDA is accelerating breakthrough psychedelic therapies for treatment-resistant depression, PTSD, and alcohol use disorder after a presidential directive. Veterans and millions struggling with serious mental illness could gain access to promising new options backed by rigorous science.
The FDA just gave breakthrough status to the first generative AI chatbot designed to guide patients through recovery after joint replacement surgery. The move signals how AI could soon help millions of people heal better at home.
The FDA just gave breakthrough status to its first generative AI chatbot for patients recovering from joint replacement surgery. This marks a major step forward in how artificial intelligence could help millions heal at home.
Three psychedelic treatments for depression and PTSD could receive FDA approval as soon as this summer, potentially offering hope to millions struggling with mental health conditions. The accelerated review process cuts approval time from a year down to just weeks.
A wireless brain implant that improved memory by 19% in clinical trials just received breakthrough status from the FDA, bringing hope to 4.3 million Americans living with brain injury. The device listens to brain signals and stimulates at precisely the right moment to help form new memories.
The FDA has greenlit an emergency treatment to protect dogs and cats from New World screwworm, a dangerous parasite spreading in the southern U.S. This fast-tracked approval gives veterinarians a powerful new tool to save infected pets.
When Kyle Diamantas became FDA's top food official in 2025, critics doubted the industry lawyer with no public health background. The full story reveals how he surprised Washington insiders.
The FDA approved leucovorin for cerebral folate deficiency, a rare genetic brain disorder affecting fewer than one in a million people. The decision brings clarity after months of confusion about the drug's potential uses.
Americans will finally get access to a sunscreen ingredient Europe has used for decades, ending a 25-year gap in product innovation. The FDA's approval of bemotrizinol marks a major shift toward faster approval of safe, effective products.
The FDA just unveiled a new approval process that could bring life-saving treatments to millions of Americans with rare diseases in months instead of years. Families who've heard "wait for the science to catch up" finally have reason to hope.
A new FDA pathway could cut the time to get personalized CRISPR treatments from four years to just three months, making life-saving gene editing accessible to thousands of children born with rare genetic diseases. Baby KJ Muldoon became the first person to receive this revolutionary treatment in February 2025.
The FDA suddenly agreed to review Moderna's revolutionary mRNA flu vaccine after initially rejecting it just a week earlier. Meanwhile, scientists developed an inhaled vaccine that could protect against multiple respiratory illnesses at once.
The FDA just announced a new pathway that could bring life-saving gene editing treatments to patients with rare diseases in record time. For families battling conditions once considered untreatable, this could change everything.
The U.S. government just launched major initiatives to phase out animal testing in drug development, backing new methods that better simulate human biology. The FDA released new guidance while the NIH committed over $150 million to institutions pioneering alternatives.
The FDA just unveiled a breakthrough framework that could bring life-saving gene therapies to thousands of children with rare diseases in a fraction of the time. For families who've watched their kids suffer while treatments stall, this changes everything.
The FDA just created a faster pathway for patients with rare genetic disorders to access personalized gene therapies without lengthy clinical trials. While some experts celebrate this breakthrough for desperately ill patients, others urge caution about adequate safety monitoring.
Showing 20 of 2841